Health-Related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR)
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.318
https://www.valueinhealthjournal.com/article/S1098-3015(17)30652-6/fulltext
Title :
Health-Related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30652-6&doi=10.1016/j.jval.2017.08.318
First page :
A454
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
297